Delivery Order SPE2DR25D2104-SPE2DR26F3QEB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,375.23 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,149.10 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed-price contract. The award was made on October 22, 2025, with an ultimate completion date of October 23, 2025, and represents a non-competitive delivery order issued under an existing contract vehicle. The products will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.09 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 8, 2025. This award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and will be fulfilled from the company's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,224.30 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed price contract. The award, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,978.92 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed-price contract. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and represents a non-set-aside, competitively awarded delivery order. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.72 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.03 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. This non-set-aside award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QEBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,163.34 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. This non-set-aside award, issued on December 1, 2025, represents a single delivery order for pharmaceutical products with an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp's consistent history of competitively awarded contracts with the DLA demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 11/30/25 |